Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

Background: The development of radiopharmaceuticals containing 225Ac for targeted alpha
therapy is an active area of academic and commercial research worldwide. Objectives …

Recent clinical results have demonstrated remarkable treatment responses of late-stage
cancer patients when treated with alpha-emitting radionuclides such as actinium-225 …

Many studies over the past few decades have been devoted to addressing the application of
diglycolamides (DGAs) for hydrometallurgical-based, f-element separations. Work to date …

Purpose We demonstrate cyclotron production of high-quality 225Ac using an electroplated
226Ra target. Methods 226Ra was extracted from legacy Ra sources using a chelating …

Targeted alpha therapy, where highly cytotoxic doses are delivered to tumor cells while
sparing surrounding healthy tissue, has emerged as a promising treatment against cancer …

The use of α-emitting radionuclides in targeted alpha therapy (TAT) holds great potential for
treatment of human diseases, such as cancer, due to the short pathlength and high potency …

Solvent extraction of Eu3+ and Am3+ via N, N, N′, N'-tetraoctyl diglycolamide (TODGA)
dissolved in different molecular diluents was studied. The diluent types used in this work …

Low–cost biosorbents (ginkgo leaf, osmanthus leaf, banyan leaf, magnolia leaf, holly leaf,
walnut shell, and grapefruit peel) were evaluated in the simultaneous removal of La3+ …

The relative stability constants of Tb (III) complexes exhibiting binding to a series of 4-
substituted analogues of dipicolinic acid (2, 6-pyridinedicarboxylic acid)(DPA) were …